GMV’s Big Data platform, the only specialized one of its kind for the health sector in Spain

GMV has presented HEXIN during the 23rd National Healthcare IT Conference of Andalusia (XXIII Jornadas Nacionales de Informática Sanitaria de Andalucía) organized by the Spanish Healthcare IT Society (Sociedad Española de Informática de la Salud: SEIS) with the collaboration of the Regional Council of Andalusia (Junta de Andalucía). HEXIN is the Big-Data-based epidemiology- and clinical-data mining solution set up by the Galician Health Service using GMV technology.

Big Data as applied to the healthcare sector opens up all the following possibilities: drawing up predictive models and behavior patterns, discovering new needs, reducing risks and providing more personalized services, all in real time and taking all relevant information into account.

Carlos Royo, GMV’s Director of Healthcare Business Development; Rafael Navajo, GMV’s Healthcare Business Development Manager; Inmaculada Pérez, Director of the Eastern Region of GMV Secure e-Solutions, and Guillermo Vázquez, Subdirector of Information Systems in the Integrated Management Office of A Coruña all gave a joint presentation from both the provider’s and user’s viewpoint. They all stressed the duty of compiling all possible patient data through the various communication channels, extracting from it priceless insights that will help not only to prevent or detect diseases but also buoy up the whole healthcare system and provide grist for meaningful research.

Rafael Navajo, GMV’s Director of Healthcare Business Development, stressed that the highly sensitive nature of the data dealt with in the healthcare sector, and especially on the HEXIN platform, meant that the security and protection of this data had to be backed up by all guarantees, precisely as offered by GMV to the Galician Health Service.

Guillermo Vázquez, for his part, referred to the various use cases now working with HEXIN, such as rare diseases, chronic pathologies, clinical research to identify the type of stents most suitable for patients, monitoring of patient symptoms and nosocomial infections (those picked up in the hospital itself).

To wind up, Inmaculada Pérez pointed out that the significance of evidence depended on “the questions asked and the sources the information comes from”.

No other region in the whole of Spain runs a clinical- and epidemiological-data mining platform like the one set up by the Galician Health Service with GMV technology.